Terms: = Breast cancer AND NT5C2, ENSG00000076685, 22978, P49902, PNT5, NT5B, GMP, cN-II
94 results:
1. The Role of the Toll-like Receptor 2 and the cGAS-STING Pathways in breast cancer: Friends or Foes?
Cossu C; Di Lorenzo A; Fiorilla I; Todesco AM; Audrito V; Conti L
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203626
[TBL] [Abstract] [Full Text] [Related]
2. ENPP1 is an innate immune checkpoint of the anticancer cGAMP-STING pathway in breast cancer.
Wang S; Böhnert V; Joseph AJ; Sudaryo V; Skariah G; Swinderman JT; Yu FB; Subramanyam V; Wolf DM; Lyu X; Gilbert LA; Van't Veer LJ; Goodarzi H; Li L
Proc Natl Acad Sci U S A; 2023 Dec; 120(52):e2313693120. PubMed ID: 38117852
[TBL] [Abstract] [Full Text] [Related]
3. Triple-negative breast tumors are dependent on mutant p53 for growth and survival.
Dibra D; Moyer SM; El-Naggar AK; Qi Y; Su X; Lozano G
Proc Natl Acad Sci U S A; 2023 Aug; 120(34):e2308807120. PubMed ID: 37579145
[TBL] [Abstract] [Full Text] [Related]
4. Activatable Mn
Liang Q; Chen J; Hou S; Li D; Zhu Y; Li R; Chen L; Li J; Fu W; Lei S; Zhang B; Zheng X; Zhang T; Duan H; He W; Ren J
Biomaterials; 2023 Sep; 300():122206. PubMed ID: 37348325
[TBL] [Abstract] [Full Text] [Related]
5. Osteoprogenitor-gmp crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removal.
Hao X; Shen Y; Chen N; Zhang W; Valverde E; Wu L; Chan HL; Xu Z; Yu L; Gao Y; Bado I; Michie LN; Rivas CH; Dominguez LB; Aguirre S; Pingel BC; Wu YH; Liu F; Ding Y; Edwards DG; Liu J; Alexander A; Ueno NT; Hsueh PR; Tu CY; Liu LC; Chen SH; Hung MC; Lim B; Zhang XH
Cell Stem Cell; 2023 May; 30(5):648-664.e8. PubMed ID: 37146584
[TBL] [Abstract] [Full Text] [Related]
6. A maladaptive pleural environment suppresses preexisting anti-tumor activity of pleural infiltrating T cells.
Donnenberg VS; Luketich JD; Sultan I; Lister J; Bartlett DL; Ghosh S; Donnenberg AD
Front Immunol; 2023; 14():1157697. PubMed ID: 37063842
[TBL] [Abstract] [Full Text] [Related]
7. Comprehensive analysis of NT5DC family prognostic and immune significance in breast cancer.
Jia Y; Li J; Wu H; Wang W; Sun S; Feng C; Liu X; Li C; Zhang Y; Cai Y; Wei X; Yao P; Liu X; Zhang S; Wu F
Medicine (Baltimore); 2023 Feb; 102(6):e32927. PubMed ID: 36820551
[TBL] [Abstract] [Full Text] [Related]
8. gmp-Compliant Mesenchymal Stem Cell-Derived Exosomes for Cell-Free Therapy in cancer.
Arjmand B; Alavi-Moghadam S; Rezaei-Tavirani M; Kokabi-Hamidpour S; Arjmand R; Gilany K; Rajaeinejad M; Rahim F; Namazi N; Larijani B
Methods Mol Biol; 2024; 2736():163-176. PubMed ID: 36515892
[TBL] [Abstract] [Full Text] [Related]
9. Centrosome de-clustering of cancer cells induces cGAS-STING-mediated innate immunity of tumor-associated tumor cells in response to irradiation.
Kim S; Choe MH; Oh JS; Kim JS
Biochem Biophys Res Commun; 2022 Dec; 636(Pt 2):24-30. PubMed ID: 36343487
[TBL] [Abstract] [Full Text] [Related]
10. A Brief Review of Radioactive Materials for Therapeutic and Diagnostic Purposes.
Bharti M; Alam MA; Rao GSNK; Sharma PK
Curr Radiopharm; 2023; 16(1):23-37. PubMed ID: 36306460
[TBL] [Abstract] [Full Text] [Related]
11. AVA-NP-695 Selectively Inhibits ENPP1 to Activate STING Pathway and Abrogate Tumor Metastasis in 4T1 breast cancer Syngeneic Mouse Model.
Goswami A; Deb B; Goyal S; Gosavi A; Mali M; Martis AM; Khurana P; Gangar M; Raykar D; Mohanty A; Kulkarni A
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235254
[TBL] [Abstract] [Full Text] [Related]
12. MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer.
Kitajima S; Tani T; Springer BF; Campisi M; Osaki T; Haratani K; Chen M; Knelson EH; Mahadevan NR; Ritter J; Yoshida R; Köhler J; Ogino A; Nozawa RS; Sundararaman SK; Thai TC; Homme M; Piel B; Kivlehan S; Obua BN; Purcell C; Yajima M; Barbie TU; Lizotte PH; Jänne PA; Paweletz CP; Gokhale PC; Barbie DA
Cancer Cell; 2022 Oct; 40(10):1128-1144.e8. PubMed ID: 36150391
[TBL] [Abstract] [Full Text] [Related]
13. DNA damage induces STING mediated IL-6-STAT3 survival pathway in triple-negative breast cancer cells and decreased survival of breast cancer patients.
Vasiyani H; Mane M; Rana K; Shinde A; Roy M; Singh J; Gohel D; Currim F; Srivastava R; Singh R
Apoptosis; 2022 Dec; 27(11-12):961-978. PubMed ID: 36018392
[TBL] [Abstract] [Full Text] [Related]
14. Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical trial): safety profile assessment.
Aghayan HR; Salimian F; Abedini A; Fattah Ghazi S; Yunesian M; Alavi-Moghadam S; Makarem J; Majidzadeh-A K; Hatamkhani A; Moghri M; Danesh A; Haddad-Marandi MR; Sanati H; Abbasvandi F; Arjmand B; Azimi P; Ghavamzadeh A; Sarrami-Forooshani R
Stem Cell Res Ther; 2022 Jul; 13(1):365. PubMed ID: 35902979
[TBL] [Abstract] [Full Text] [Related]
15. Complexes of copper(II) with tetradentate S,O-ligands: Synthesis, characterization, DNA/albumin interactions, molecular docking simulations and antitumor activity.
Živanović AS; Bukonjić AM; Jovanović-Stević S; Bogojeski J; Ćoćić D; Bijelić AP; Ratković ZR; Volarević V; Miloradović D; Tomović DL; Radić GP
J Inorg Biochem; 2022 Aug; 233():111861. PubMed ID: 35599165
[TBL] [Abstract] [Full Text] [Related]
16. Immune activation of the monocyte-derived dendritic cells using patients own circulating tumor cells.
Kolostova K; Pospisilova E; Matkowski R; Szelachowska J; Bobek V
Cancer Immunol Immunother; 2022 Dec; 71(12):2901-2911. PubMed ID: 35471603
[TBL] [Abstract] [Full Text] [Related]
17. Anticancer and chemosensitization effects of cannabidiol in 2D and 3D cultures of TNBC: involvement of GADD45α, integrin-α5, -β5, -β1, and autophagy.
Surapaneni SK; Patel N; Sun L; Kommineni N; Kalvala AK; Gebeyehu A; Arthur P; Duke LC; Nimma R; G Meckes D; Singh M
Drug Deliv Transl Res; 2022 Nov; 12(11):2762-2777. PubMed ID: 35217991
[TBL] [Abstract] [Full Text] [Related]
18. EZH2-CCF-cGAS Axis Promotes breast cancer Metastasis.
Duan D; Shang M; Han Y; Liu J; Liu J; Kong SH; Hou J; Huang B; Lu J; Zhang Y
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163710
[TBL] [Abstract] [Full Text] [Related]
19. Preclinical evaluation of [
Estrada S; Elgland M; Selvaraju RK; Mani K; Tegler G; Wanhainen A; Wågsäter D; Bergström M; Jimenez-Royo P; Jahan M; Nordeman P; Antoni G
Nucl Med Biol; 2022; 106-107():62-71. PubMed ID: 35066391
[TBL] [Abstract] [Full Text] [Related]
20. Pros and Cons of Pharmacological Manipulation of cgmp-PDEs in the Prevention and Treatment of breast cancer.
Di Iorio P; Ronci M; Giuliani P; Caciagli F; Ciccarelli R; Caruso V; Beggiato S; Zuccarini M
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008687
[TBL] [Abstract] [Full Text] [Related]
[Next]
